All content for From Lab to Life is the property of Bellberry Ltd and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Worldwide there is growing focus on using NAMs (Non-Animal Models also known as Novel Approach Methods) in the development of therapeutics. In other words, removing animals from pre-clinical testing.
In this episode of From Lab to Life, we take you to a NAM symposium hosted by Bellberry and ASCEPT (Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists) held late in 2024.
